Osteonic Co. Ltd (226400) — Capital Reinvestment Ratio
Latest as of September 2025:
1.39x
Osteonic Co. Ltd (226400) has a Capital Reinvestment Ratio of 1.39x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩1.09 Billion) in capital expenditures (₩1.52 Billion). See cash generation quality of Osteonic Co. Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.39x
Capex / Operating Cash Flow
Operating Cash Flow
₩1.09 Billion
KRW
Capital Expenditures
₩1.52 Billion
KRW
Data as of
Sep 2025
Most recent filing
Osteonic Co. Ltd Capital Reinvestment Ratio (2018–2024)
This chart tracks Osteonic Co. Ltd's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Osteonic Co. Ltd (2018–2024)
Year-by-year Capital Reinvestment Ratio for Osteonic Co. Ltd from 2018 to 2024. For live market cap and broader valuation context, see 226400 market cap overview.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.49x | ₩4.72 Billion | ₩7.05 Billion | ▼ -11.3% |
| 2023 | 1.68x | ₩4.14 Billion | ₩6.97 Billion | ▲ +1294.5% |
| 2022 | 0.12x | ₩3.99 Billion | ₩481.34 Million | ▼ -62.1% |
| 2021 | 0.32x | ₩2.95 Billion | ₩939.46 Million | ▼ -7.5% |
| 2020 | 0.34x | ₩2.75 Billion | ₩949.15 Million | ▼ -97.9% |
| 2018 | 16.58x | ₩317.53 Million | ₩5.26 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow